Next Breath, a division of AptarGroup Inc. is a cGMP compliant laboratory located in Baltimore, Maryland and was founded by Dr. Julie Suman and Dr. Shailaja Somaraju. Next Breath is viewed as an intellectual leader in the field of inhalation and nasal spray development, testing and regulatory strategy. Next Breath is an active member of the OINDP community. We participate in seminars and educational workshops at leading conferences (RDD, DDL, IPAC-RS and AAPS among others). Next Breath also regularly contributes to development of standard practices through leadership in the Inhalation and Nasal Technology Focus Group and OINDP committees.
Since inception, Next Breath has collaborated with over 65 pharmaceutical companies and has contributed towards several successful regulatory submissions in domestic and international markets.

Next Breath is currently responsible for the CMC (Chemistry, Manufacturing and Controls) components of two inhaled antiviral and antibiotic DPI drug development process for a multi-year $50 million contract under  Bioshield program funded and administrated by the National Institute of Health (NIH) and the Biomedical Advanced Research and Development Authority (BARDA). In this capacity, Next Breath is responsible for the entire CMC and stability package for submission to the FDA.

Next Breath’s Values

We are an organization based on energetic teamwork, intellect, integrity, discipline and mutual respect. Our employees are our greatest asset. We understand that our reputation is promulgated upon compliance and good scientific principles. We realize the importance in providing our clients with completed programs that are on time, on budget and technically superior.

Next Breath Lab